Posts for Ticker ‘PRXL’

Top Analyst Upgrades (AKAM, BSX, CLX, CVA, ESRX, MCRS, PRXL, PFE, QSII, SGMS)

Money_stack_picThese are some of the top analyst upgrades and positive calls we are seeing this Monday morning:

  • Akamai (AKAM) Raised to Buy at Merriman Curhan Ford.
  • Boston Scientific (BSX) Raised to Overweight at Thomas Weisel.
  • Clorox (CLX) Raised to Buy at Goldman Sachs.
  • Covanta (CVA) Raised to Overweight at JPMorgan.
  • Express Scripts (ESRX) Raised to Buy at Goldman Sachs.
  • Micros Systems (MCRS) Started as Outperform at Oppenheimer.
  • PAREXEL (PRXL) Raised to Outperform at Wachovia.
  • Pfizer (PFE) Raised to Outperform at Credit Suisse.
  • Quality Systems (QSII) Raised to Buy at Piper Jaffray.
  • Scientific Games (SGMS) Raised to Buy at Goldman Sachs.

Jon C. Ogg
February 2, 2009

Posted on: February 2, 2009 – 7:48 am in Analyst Calls, , , , , , , , , ,

The 52-Week Low Club (PDGI)(PRXL)(LVS)(USG)(MF)(CVG)

Sad_clownConvergys (CVG) Posts a loss and weak forecast. Drops to $6.82 from 52-week high of $19.18.

MF Global (MF) No major news. Drops to $1.93 from 52-week high of $32.20.

USG Corporation (USG) May have violated lending agreement. Falls to $14.23 from 52-week high of $40.25.

Las Vegas Sands (LVS) Casino stocks out of vogue. Sells down to $4.32 from 52-week high of $148.76.

PAREXEL International (PRXL) Revenue shortfall. Plummets to $6.84 from 52-week high of $36.16.

Pharmanet (PDGI) No news. Sells off to $1 from 52-week high of $43.02.

Douglas A. McIntyre

Posted on: October 28, 2008 – 3:01 pm in HI/LOW, , , , , ,

High Volume Stock Tankers (GS, MS, DWT, CRDN, ACF, PRXL)

Down_arrow_redWe are seeing many high volume price drops in actively traded shares today.  In most cases, the earnings are to blame, but there are other issues affecting some stocks as well.  Goldman Sachs Group (NYSE: GS), Morgan Stanley (NYSE: MS), Britannia Bulk Holdings Inc. (NYSE: DWT), AmeriCredit (NYSE: ACF), Ceradyne Inc. (NASDAQ: CRDN), and Paraxel International Corp. (NASDAQ: PRXL) are all being hit on strong trading volume.  Below are links for a full synopsis on each.

Read More »

Posted on: October 28, 2008 – 10:42 am in HI/LOW, Trading Alert, , , , , ,

Top Pre-Market Analyst Upgrades (BXP, DWA, DUK, MET, MTB, PRXL, POR, PFG, PSA, UDR)

These are some of the top pre-market analyst calls we are seeing this Friday morning:

  • Boston Properties (BXP) Raised to Outperform at FBR.
  • DreamWorks Animation (DWA) Raised to Buy at Jefferies.
  • Duke Energy (DUK) Raised to Neutral at Goldman Sachs.
  • MetLife (MET) Resumed at Overweight at Morgan Stanley.
  • M&T Bank Corp (MTB) Raised to Neutral at Baird.
  • Parexel (PRXL) Raised to Outperform at William Blair.
  • Portland General (POR) Raised to Buy at Goldman Sachs.
  • Principal Financial (PFG) Raised to Equal-weight at Morgan Stanley.
  • Public Storage (PSA) Raised to Outperform at Wachovia.
  • UDR Inc. (UDR) Raised to Outperform at FBR.

Jon C. Ogg
October 10, 2008

Posted on: October 10, 2008 – 7:02 am in Analyst Calls, , , , , , , , , ,

Major March Short Interest Increases (CSCO, LOGI, MCRL, PRXL, PTEN, SPLS, JAVA, TROW, YRCW)

We routinely look over major changes in short interest from period to period.  While the more frequent twice-monthly reporting is conducted by exchanges, it sometimes gives a little insight into the psyche of traders and trends.  The most important issue to look at is in the larger and more active names that have large positions that grew rapidly in percentage terms.

We screened many different names after the short interest data came out last night from NASDAQ, so we looked for a minimum of 5 million shares short and we looked for those names whose short interest grew by more than 30%.  These are not all of the names, but here is a representation of the screen:

Comapny (Ticker)                              MARCH 14     FEB 29       CHANGE
Cisco Systems, Inc. (CSCO)          73,069,889   48,631,811    50.25%
Logitech International (LOGI)           8,017,620    5,464,404     46.72%
Micrel, Incorporated (MCRL)             7,719,618    5,242,192     47.26%
PAREXEL International (PRXL)        6,204,152    3,137,862     97.72%
Patterson-UTI Energy (PTEN)         14,068,305    9,336,158    50.69%
Staples, Inc. (SPLS)                          20,708,717   15,097,693   37.16%
Sun Microsystems (JAVA)                23,630,955   17,562,322   34.55%
T. Rowe Price Group (TROW)         15,997,024   11,341,287   41.05%
YRC Worldwide, Inc. (YRCW)          22,782,135   16,007,172   42.32%

Jon C. Ogg
March 27, 2008

Jon Ogg produces the Special Situation Investing Newsletter and can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: March 27, 2008 – 7:57 am in Short Interest, , , , , , , , ,

Cramer’s Drug Research/CRO Stocks (CVD, PRXL)

On tonight’s MAD MONEY on CNBC, Jim Cramer came out with a positive tease early on in the contract research organization sector (CRO’s) as it pertains to drugs, biotech, and medical research.  He thinks this sector is recession proof and is set to continue growing whether the market rises or falls.  For growth and cost cutting this sector is mandatory for an ailing drug and pharma sector.  His picks tonight were:

  • His pick that does both early and late stage: Covance (NYSE: CVD) is Cramer’s best pick of the group and is 50/50 in early and late stages and a high customer diversification.  They can save customers the most by outsourcing, and the balance sheet is immaculate with new factories/offices opening.
  • Paraxel (NASDAQ:PRXL) is another he likes in the CRO sector.

This sector has seen some incredible performance over the last 12 to 18 months, yet only Quest has a $10 Billion market cap.  The multiples have gotten higher of late, but that is the price for being defensive now.  He isn’t at all convinced that today is the start of a market trend and he thinks the market will roll over again, so he wants to look at safety names besides tonight’s key oversold and overlooked tech stock picks he gave tonight.

Jon C. Ogg
January 14, 2008

Posted on: January 14, 2008 – 7:16 pm in Cramer, Drug companies, ,

Pre-Market Analyst Calls (June 27, 2007)

BRKR raised to Peer Perform at Bear Stearns.
CYT raised to Buy at Goldman Sachs.
FFIV cut to Neutral at Baird.
FIRE raised to Buy at Jefferies.
KSS raised to Outperform at Baird.
MLNM raised to Mkt Perform at FBR.
MOS cut to Neutral at Goldman Sachs.
MTH started as Hold at Deutsche Bank.
PHM started as Hold at Deutsche Bank.
PRXL raised to Peer Perform at Bear Stearns.
RYL started as Buy at Deutsche Bank.
TRS started as Buy at Goldman Sachs.
TSO cut to Sell at Citigroup.
VLO cut to Sell at Citigroup.
VMSI cut to Peer Perform at Bear Stearns.

Jon C. Ogg
June 27, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 27, 2007 – 6:54 am in Analyst Calls, , , , , , , , , , , , , , ,